100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
medschool finals question bank with answers and explanation £6.95   Add to cart

Lecture notes

medschool finals question bank with answers and explanation

 1 view  0 purchase
  • Module
  • Institution

a question bank with answers and explanations for your medicalschool final exams

Preview 4 out of 267  pages

  • September 4, 2022
  • 267
  • 2022/2023
  • Lecture notes
  • Dr joy
  • All classes
avatar-seller
QUESTIONS
1. A 64-year-old male presents to the emergency department with ongoing crushing
left-sided chest pain radiating to the jaw which started four hours ago. He has a past
medical history of atrial fibrillation, which is managed with rate control and warfarin.
You perform an electrocardiogram and serum troponin which confirm an inferior
non-ST-elevation myocardial infarction (NSTEMI). Percutaneous coronary
intervention (PCI) is performed two days after presentation.

options?

clopidogrel

digoxin

furosemide

prasugrel

ticagrelor

answer: clopidogrel

explanation
NSTEMI (managed with PCI) antiplatelet choice:

if the patient is not taking an oral anticoagulant: prasugrel or ticagrelor

if taking an oral anticoagulant: clopidogrel

This patient is presenting with NSTEMI, which was managed with PCI. In patients
without aspirin sensitivity, dual-antiplatelet therapy is recommended post-acute
coronary syndrome (ACS) for up to 12 months. Medication options to achieve this
alongside aspirin are prasugrel, ticagrelor or clopidogrel. However, as this patient is
warfarinised (due to their comorbid AF), clopidogrel is the best medication of choice.
Digoxin is incorrect, this is an anti-arrhythmic that may occasionally be used for rate
control of AF. It is not indicated in this patient.
Furosemide is a loop diuretic commonly used in the management of heart failure
with associated fluid overload. As this patient is not showing signs of impaired
ventricular function and is not oedematous, furosemide is not indicated.



QUESTIONS 1

, Prasugrel is incorrect as the patient is currently taking warfarin.
Ticagrelor is incorrect as the patient is currently taking warfarin.

notes

Acute coronary syndrome: initial management
Acute coronary syndrome (ACS) is a very common and important presentation in
medicine. The management of ACS has evolved over recent years, with the
development of new drugs and procedures such as percutaneous intervention
(PCI).
Emergency departments often have their own protocols based on local factors such
as the availability of PCI and hospital drug formularies. The following is based on
the 2020 update to the NICE ACS guidelines.
Acute coronary syndrome can be classified as follows:

ST-elevation myocardial infarction (STEMI): ST-segment elevation + elevated
biomarkers of myocardial damage

non ST-elevation myocardial infarction (NSTEMI): ECG changes but no ST-
segment elevation + elevated biomarkers of myocardial damage

unstable angina

The management of ACS depends on the particular subtype. NICE management
guidance groups the patients into two groups:

1. STEMI

2. NSTEM/unstable angina

Common management of all patients with ACS
Initial drug therapy

aspirin 300mg

oxygen should only be given if the patient has oxygen saturations < 94% in
keeping with British Thoracic Society oxygen therapy guidelines

morphine should only be given for patients with severe pain

previously IV morphine was given routinely


QUESTIONS 2

, evidence, however, suggests that this may be associated with adverse
outcomes

nitrates

can be given either sublingually or intravenously

useful if the patient has ongoing chest pain or hypertension

should be used in caution if patient hypotensive

The next step in managing a patient with suspected ACS is to determine whether
they meet the ECG criteria for STEMI. It is, of course, important to recognise that
these criteria should be interpreted in the context of the clinical history.

STEMI criteria

clinical symptoms consistent with ACS (generally of ≥ 20 minutes duration) with
persistent (> 20 minutes) ECG features in ≥ 2 contiguous leads of:

2.5 mm (i.e ≥ 2.5 small squares) ST elevation in leads V2-3 in men under
40 years, or ≥ 2.0 mm (i.e ≥ 2 small squares) ST elevation in leads V2-3 in
men over 40 years

1.5 mm ST elevation in V2-3 in women

1 mm ST elevation in other leads

new LBBB (LBBB should be considered new unless there is evidence
otherwise)




QUESTIONS 3

, Once a STEMI has been confirmed the first step is to immediately assess
eligibility for coronary reperfusion therapy. There are two types of coronary
reperfusion therapy:

primary coronary intervention

should be offered if the presentation is within 12 hours of the onset of
symptoms AND PCI can be delivered within 120 minutes of the time
when fibrinolysis could have been given (i.e. consider fibrinolysis if
there is a significant delay in being able to provide PCI)

if patients present after 12 hours and still have evidence of ongoing
ischaemia then PCI should still be considered

drug-eluting stents are now used. Previously 'bare-metal' stents were
sometimes used but have higher rates of restenosis

radial access is preferred to femoral access

fibrinolysis

should be offered within 12 hours of the onset of symptoms if primary
PCI cannot be delivered within 120 minutes of the time when fibrinolysis
could have been given

a practical example may be a patient who presents with a STEMI to a
small district general hospital (DGH) that does not have facilities for
PCI. If they cannot be transferred to a larger hospital for PCI within 120
minutes then fibrinolysis should be given. If the patient's ECG taken 90
minutes after fibrinolysis failed to show resolution of the ST elevation
then they would then require transfer for PCI

If patients are eligible this should be offered as soon as possible.

Primary coronary intervention for patients with STEMI
Further antiplatelet prior to PCI

this is termed 'dual antiplatelet therapy', i.e. aspirin + another drug

if the patient is not taking an oral anticoagulant: prasugrel

if taking an oral anticoagulant: clopidogrel




QUESTIONS 4

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller suvieshapillai. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for £6.95. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

72964 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy revision notes and other study material for 14 years now

Start selling
£6.95
  • (0)
  Add to cart